Identification of O2-substituted pyrimidine adducts formed in reactions of 4-(acetoxymethylnitrosamino)1-(3-pyridyl)-1-butanone and 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanol with DNA

被引:52
|
作者
Hecht, SS [1 ]
Villalta, PW [1 ]
Sturla, SJ [1 ]
Cheng, G [1 ]
Yu, NX [1 ]
Upadhyaya, P [1 ]
Wang, MY [1 ]
机构
[1] Univ Minnesota, Ctr Canc, Minneapolis, MN 55455 USA
关键词
D O I
10.1021/tx034263t
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Metabolic hydroxylation of the methyl group of the tobacco specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) results in the formation of intermediates that can alkylate DNA. Similarly, metabolic hydroxylation of the 2'-position of the tobacco specific carcinogen N'-nitrosonornicotine gives DNA alkylating intermediates. The resulting pyridyloxobutyl and pyridylhydroxybutyl adducts with dGuo have been characterized, but there are no reports of pyrimidine adducts. Therefore, in this study, we investigated the reactions of 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone (NNKCH2OAc) and 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanol (NNALCH(2)OAc) with DNA, dCyd, and dThd. NNKCH2OAc and NNALCH(2)OAc are stable precursors to the products formed upon metabolic methyl hydroxylation of NNK and NNAL. Analysis by LC-ESI-SIM of enzyme hydrolysates of DNA that had been allowed to react with NNKCH2OAc and NNALCH(2)OAc demonstrated the presence of major adducts with dCyd and dThd. The dCyd adducts were thermally unstable, releasing 4-HPB (18) or 4-hydroxy-1-(3-pyridyl)-1-butanol (25) upon treatment at 100 degreesC, pH 7.0. The dThd adducts were stable under these conditions. The dCyd adduct of NNALCH(2)OAc was characterized by its MS and UV and by conversion upon neutral thermal hydrolysis to the corresponding Cyt adduct, which was identified by MS, UV, and NMR. The dCyd and Cyt adducts of NNKCH2OAc were similarly characterized. The dThd adduct of NNKCH2OAc was identified by MS, UV, and NMR. Treatment of this adduct with NaBH4 gave material, which was identical to that produced upon reaction of NNALCH(2)OAc with DNA or dThd. These data demonstrate that the major pyrimidine adducts formed in the reactions of NNKCH2OAc with DNA are O-2[4-(3-pyridyl)-4-oxobut-1-yl]dCyd (26) and O-2[4-(3-pyridyl)-4-oxobut-1-yl]dThd (30) while those produced from NNALCH(2)OAc are O-2[4-(3-pyridyl)-4-hydroxybut-1-yl]dCyd (28) and O-2[4-(3-pyridyl)-4-hydroxybut-1-yl]dThd (31). Levels of these pyrimidine adducts of NNKCH2OAc in DNA were substantially greater than those of the dGuo adducts of NNKCH2OAc, based on MS peak area. Furthermore, 26 was identified as a major 4-HPB releasing adduct of NNKCH2OAc. These results suggest that pyrimidine adducts of tobacco specific nitrosamines may be important contributors to their mutagenic and carcinogenic activity.
引用
收藏
页码:588 / 597
页数:10
相关论文
共 50 条
  • [31] Disposition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in bile duct-cannulated rats: Stereoselective metabolism and tissue distribution
    Wu, Z
    Upadhyaya, P
    Carmella, SG
    Hecht, SS
    Zimmerman, CL
    CARCINOGENESIS, 2002, 23 (01) : 171 - 179
  • [32] Formation and stability of 4-(hydroxymethylnitrosamino)-1-(3-pyridyl)-1-butanone glucuronide, a stable form of reactive intermediate produced from 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, in mice
    Nishiyama, Takahito
    Hayashi, Nahoko
    Kakurai, Naoki
    Yanagita, Hiromi
    Kuriyama, Ai
    Miyamoto, Chika
    Ishihara, Yumi
    Ogura, Kenichiro
    Ohnuma, Tomokazu
    Hiratsuka, Akira
    JOURNAL OF TOXICOLOGICAL SCIENCES, 2014, 39 (04): : 515 - 521
  • [33] Metabolic study of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone to the enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in vitro in human bronchial epithelial cells using chiral capillary electrophoresis
    Yang, Youyou
    Yu, Cong
    Zhou, Meng
    Pang, Nannan
    Li, Ning
    Nie, Honggang
    Liao, Jie
    Bai, Yu
    Liu, Huwei
    JOURNAL OF CHROMATOGRAPHY A, 2011, 1218 (37) : 6505 - 6510
  • [34] INVIVO AND INVITRO PERSISTENCE OF PYRIDYLOXOBUTYL DNA ADDUCTS FROM 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE
    PETERSON, LA
    MATHEW, R
    MURPHY, SE
    TRUSHIN, N
    HECHT, SS
    CARCINOGENESIS, 1991, 12 (11) : 2069 - 2072
  • [35] Comparative metabolism of the tobacco-related carcinogens benzo[a]pyrene, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and N'-nitrosonornicotine in human hepatic microsomes
    Staretz, ME
    Murphy, SE
    Patten, CJ
    Nunes, MG
    Koehl, W
    Amin, S
    Koenig, LA
    Guengerich, FP
    Hecht, SS
    DRUG METABOLISM AND DISPOSITION, 1997, 25 (02) : 154 - 162
  • [36] IDENTIFICATION OF 4-(METHYLNITROSAMINO)-1-[3-(6-HYDROXYPYRIDYL)]-1-BUTANONE AS A URINARY METABOLITE OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE IN RODENTS
    DESAI, D
    KAGAN, SS
    AMIN, S
    CARMELLA, SG
    HECHT, SS
    CHEMICAL RESEARCH IN TOXICOLOGY, 1993, 6 (06) : 794 - 799
  • [37] Inhibition of metabolic activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by limonene
    Morse, MA
    Toburen, AL
    CANCER LETTERS, 1996, 104 (02) : 211 - 217
  • [38] INHIBITION OF METABOLISM OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE BY DIETARY BENZALDEHYDES
    MORSE, MA
    KRESTY, LA
    TOBUREN, AL
    CANCER LETTERS, 1995, 97 (02) : 255 - 261
  • [39] METABOLISM OF A GLUCURONIDE CONJUGATE OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE IN RATS
    ATAWODI, SEO
    MICHELSEN, K
    RICHTER, E
    ARCHIVES OF TOXICOLOGY, 1994, 69 (01) : 14 - 17
  • [40] BILIARY-EXCRETION OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE IN THE RAT
    SCHULZE, J
    RICHTER, E
    BINDER, U
    ZWICKENPFLUG, W
    CARCINOGENESIS, 1992, 13 (11) : 1961 - 1965